V
Viz
AI-powered medical imaging analysis and care coordination
About Viz
Viz.ai develops artificial intelligence software for disease detection and care coordination. Headquartered in San Francisco, it was founded in 2016 by co-founders Chris Mansi and David Golan.
Its software analyzes clinical data including CT scans, EKGs and echocardiograms to support diagnosis and treatment decisions. For healthcare providers, its care pathways identify patients needing follow-up and send notifications to multidisciplinary teams through desktop and mobile applications.
Viz.ai also works with pharmaceutical and medical device companies to develop disease-specific applications integrated into clinical workflows.
Source: Dealroom company dataNews
Open roles
Viz in the San Francisco ecosystem
The Viz office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
Series A7 investors entered at this stage
Pear Ventures
Techammer
DHVC (Danhua Capital)
Kleiner Perkins
Greenoaks Capital Partners
Threshold Ventures
CRV
Series B and later10 investors entered at this stage
Scale Venture Partners
Insight Partners- SVSOSA Ventures
Tiger Global
Scale Ventures
Susa Ventures
Sozo Ventures
CIBC Innovation Banking
Bristol-Myers Squibb
Hakluyt Capital
Source: Dealroom Talent Intelligence.
Patents
6 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Viz on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.




